All the news Showing 8 of 8 articles from: CirrhosisGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources FDA Grants Priority Review to AbbVie for Supplemental New Drug Application for VIEKIRA PAK® without Ribavirin in Genotype 1b Compensated Cirrhosis AbbVie press release / 11 January 2016 Adding ribavirin to Harvoni for hepatitis C increases side effects but not efficacy HIVandHepatitis.com / 29 June 2015 NHS England announces 'huge investment' for new hepatitis C treatments The Pharmaceutical Journal / 16 June 2015 Treatment For Welsh Hepatitis C Patients With Advanced Liver Disease Swansea Sound / 08 June 2015 Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis Bristol-Myers Squibb press release / 10 November 2014 AbbVie Completes Largest Phase III Program of an All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C Genotype 1 AbbVie press release / 31 January 2014 Sign-on letter to Gilead about sofosbuvir TRT-5 / 29 July 2013 Abbott Announces Phase 3 Interferon-free Hepatitis C Regimens to be Studied in Broad Patient Populations Abbott press release / 14 November 2012 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive